Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Zinc Sulphate and Ursodeoxycholic Acid as Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia
NCT06517862Phase 4Completed
- Start
- Sep 2024
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of zinc, ursodeoxycholic acid in neonatal hyperbilirubinemia. Started Sep 2024; status: completed.
02
Drugs
zincursodeoxycholic acid
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on NCT06517862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06517862.